Fluidda is a both a clinical research organization (CRO) and a partner to healthcare professionals as a leader in the field of Functional Respiratory Imaging (FRI). This technique enables shorter, faster, and more cost effective clinical trials. The mission is to optimize treatment pathways, reduce healthcare costs and limit the go-to-market time of respiratory drugs, pulmonary medical devices, and therapies.
Three Lakes Foundation is a member of the Fluidda Consortium that is collecting and analyzing HRCT scans of COVID 19 patients. For more information about the company, visit: Fluidda.com